PB2294: CHEMOTHERAPY INDUCED THROMBOCYTOPENIA AND ITS ASSOCITAION WITH COAGULOPATHY; A SINGLE CENTRE EXPERIENCE

PB2294: CHEMOTHERAPY INDUCED THROMBOCYTOPENIA AND ITS ASSOCITAION WITH COAGULOPATHY; A SINGLE CENTRE EXPERIENCE

Bibliographic Details
Main Authors:	N. ANWAR, N. FATIMA, A. KHALID, L. MAJEED, M. BORHANY
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000852004.28500.0e

Similar Items

PB1920: CLINICOHEMATOLIGICAL CHARACTERISTICS AND CYTOGENETIC PROFILE OF CHRONIC MYELOMONOCYTIC LEUKEMIA; AN EXPERIENCE FROM PAKISTAN
by: N. ANWAR, et al.
Published: (2022-06-01)

PB2255: ANTIMICROBIAL SUSCEPTIBILITY TO MICROORGANISMS IN HEMATOLOGICAL MALIGNANCIES; A NEED TO REVIEW INSTITUTIONAL PROTOCOLS
by: N. ANWAR, et al.
Published: (2022-06-01)

PB2240: TREATMENT OUTCOME OF CHRONIC MYELOMONOCYTIC LEUKEMIA; A SINGLE CENTRE EXPERIENCE FROM PAKISTAN
by: Nida Anwar, et al.
Published: (2023-08-01)

PB2618: USE AND DISCONTINUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SINGLE CENTRE EXPERIENCE
by: Celia Martinez, et al.
Published: (2023-08-01)

Rapidly involuting congenital haemangioma (RICH) associated with transient thrombocytopenia and coagulopathy
by: Ana María Palma, et al.
Published: (2024-04-01)

PB2050: EVALUATION OF NON-CLONAL ERYTHROCYTOSIS: SINGLE CENTRE EXPERIENCE
by: A. Šumah, et al.
Published: (2022-06-01)

PB2294: DOSE-ADJUSTED EDOCH AS FIRST-LINE THERAPY IMPROVED PROGNOSIS OF ADULT T-CELL LEUKEMIA/LYMPHOMA: A 11-YEAR MULTICENTER RETROSPECTIVE STUDY IN CHINA
by: Luting Luo, et al.
Published: (2023-08-01)

Coagulopathy in hospitalized COVID-19 patients: A single-center experience
by: Marwa Kasim Ahmed, et al.
Published: (2022-01-01)

The prevalence of thrombocytopenia in pregnant women in Baghdad: single centre study
by: Eaman M. Muhammad, et al.
Published: (2018-09-01)

PB2637: OUR EXPERIENCE WITH AVATROMBOPAG TREATMENT IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA
by: Libor Cervinek
Published: (2023-08-01)

PB2031: NEXT GENERATION SEQUENCING IN MYELOID NEOPLASMS: DEVELOPING WORLD DATA FROM SINGLE CENTRE
by: Nida Anwar, et al.
Published: (2023-08-01)

PB2606: REAL-WORLD EXPERIENCE OF HETROMBOPAG IN RELAPSE AND REFRACTORY IMMUNE THROMBOCYTOPENIA
by: Yimei Feng, et al.
Published: (2023-08-01)

PB2652: EVALUATION OF 6 CASES WITH FXIII DEFICIENCY: SINGLE CENTRE EXPERIENCE
by: Fahri Sahin, et al.
Published: (2023-08-01)

PB2299: CLINICAL AND LABORATORY CHARACTERISTICS OF CHILDREN WITH INHERITED THROMBOCYTOPENIA IN A SINGLE EGYPTIAN UNIVERSITY HOSPITAL
by: Y. El Chazli, et al.
Published: (2022-06-01)

Qing-Fei-Pai-Du Decoction ameliorated coagulopathy and thrombocytopenia in endotoxaemia rats and enhanced platelet production from megakaryocytes
by: Jiao Wu, et al.
Published: (2023-12-01)

Utilisation of blood products at a centre in Pakistan. Is donating better than wasting?
by: Haya Ul Mujtaba, et al.
Published: (2020-10-01)

PB2306: RELAPSE OF IMMUNE THROMBOCYTOPENIA AND MYOCARDITIS
by: F. Kapsouli, et al.
Published: (2022-06-01)

Traumatic Coagulopathy
by: Joong Suck Kim, et al.
Published: (2015-10-01)

PB2610: EPIDEMIOLOGY AND TREATMENT OF ITP: A SINGLE CENTRE, REAL-WORLD EXPERIENCE
by: Priya Patel, et al.
Published: (2023-08-01)

PB2319: ACQUIRED COAGULOPATHY: FACTOR X DEFICIENCY AT DIAGNOSIS OF MULTIPLE MYELOMA WITHOUT ASSOCIATED AMYLOIDOSIS
by: M. De La Torre De La Paz, et al.
Published: (2022-06-01)

PB2621: TREATMENT OF IMMUNE THROMBOCYTOPENIA WITH HETROMBOPAG—A SINGLE-CENTER RETROSPECTIVE, OBSERVATIONAL STUDY
by: Hu Zhou, et al.
Published: (2023-08-01)

Frequency and Clinical Significance of Antinuclear Antibody Positivity in Immune Thrombocytopenia in Adults
by: Rabeea Munawar Ali, et al.
Published: (2023-03-01)

Sepsis-Associated Coagulopathy
by: Scarlatescu Ecaterina, et al.
Published: (2016-10-01)

CASE OF ACQUIRED COAGULOPATHY
by: M. T. Vatutin, et al.
Published: (2018-12-01)

PB2032: FACTORS ASSOCIATED WITH TRANSFUSION INDEPENDENCY POST TREATMENT IN HIGH RISK MDS PATIENTS
by: Naveena Fatima, et al.
Published: (2023-08-01)

El Livro de Alveitaria del CÓD. 2294 de la Biblioteca Nacional de Portugal: anotaciones para su historia y descripción
by: Gerardo Pérez Barcala
Published: (2019-12-01)

PB2303: THROMBOCYTOPENIA IN COVID-19 PATIENTS ON ECMO SUPPORT
by: C. Jones, et al.
Published: (2022-06-01)

PB2685: QUALITY OF LIFE IN INDIAN ADULTS WITH IMMUNE THROMBOCYTOPENIA
by: Vivek Bhat, et al.
Published: (2023-08-01)

PB1756: EPIDEMIOLOGY OF ACUTE LYMPHOBLASTIC LEUKAEMIA: A RETROSPECTIVE 6-YEAR SINGLE CENTRE EXPERIENCE
by: Jora Kociaj, et al.
Published: (2023-08-01)

PB2243: ROSAI-DORFMAN DISEASE -A SINGLE CENTRE EXPERIENCE OF A RARE HISTIOCYTIC DISORDER
by: Harry Apperley, et al.
Published: (2023-08-01)

Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
by: Jiwon Shin, et al.
Published: (2023-05-01)

Romiplostim for chemotherapy‐induced thrombocytopenia: Efficacy and safety of extended use
by: Cy R. Wilkins, et al.
Published: (2022-03-01)

Trauma Coagulopathy and Its Outcomes
by: Gabriele Savioli, et al.
Published: (2020-04-01)

COVID-19 Related Coagulopathy
by: Seval AKPINAR
Published: (2020-12-01)

Management of Coagulopathy in Bleeding Patients
by: Stefan Hofer, et al.
Published: (2021-12-01)

Hematological Phenotype of COVID-19-Induced Coagulopathy: Far from Typical Sepsis-Induced Coagulopathy
by: Yutaka Umemura, et al.
Published: (2020-09-01)

PB2101: TREATMENT OF AGGRESSIVE B-CELL LYMPHOMA WITH DA-EPOCH-R, A SINGLE CENTRE EXPERIENCE
by: E.-K. Dimitraki, et al.
Published: (2022-06-01)

PB1956: ANALYSIS OF CLINICAL COURSE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND COMPLEX KARYOTYPE – SINGLE CENTRE EXPERIENCE
by: Sofija Sarac, et al.
Published: (2023-08-01)

PB1937: A RARE, DIFFICULT- TO- DIAGNOSE DISEASE; LANGERHANS CELL HISTIOCYTOSIS – A SINGLE CENTRE EXPERIENCE
by: Betül Kübra Tüzün, et al.
Published: (2023-08-01)

PB2623: AVATROMBOPAG FOR THE TREATMENT OF CHILDREN WITH PERSISTENT AND CHRONIC IMMUNE THROMBOCYTOPENIA
by: Qi An, et al.
Published: (2023-08-01)